Kunpeng Project
Asset repurchase lifted! A number of companies released summaries of important planning news in the early hours of the morning
Huatai Group: will repurchase with 60 million to 120 million **
Huatai Group announced that the company will increase the price of 4$8 (including $4.)8 yuan) and 6-1 yuan.
Shanghai Pharmaceutical: It has passed the clinical study of i031. 】
Shanghai Pharmaceutical announced that its "i031" has been approved by the Drug Administration of the China Medical Products Administration. I031 is a small molecule drug with antitumor activity.
Aosaikang: The dlafloxacin produced by its subsidiary has been approved by the State Food and Drug Administration. 】
Aosaikang: Jiangsu Aosaikang Pharmaceutical Co., Ltd., a holding subsidiary, has received the Chinese Pharmacopoeia approved by the Chinese Pharmacopoeia of dlafloxacin. Dracin is a new type of fluoroquinolone antibiotic, which is mainly used in clinical ** various serious chronic respiratory infectious diseases (ABSSSI).
Changshu Bank: Net profit of 32 in fiscal year 20228.2 billion, an increase of 19 over the same period last year61%】
Changshu Bank announced its 2022 annual report, and the company achieved revenue of 98 percent in 2022700 million yuan, an increase of 12 over the same period last year04%；The rights and interests of the company shall be 328.2 billion yuan, an increase of 19 over the same period last year61%；The company's earnings per share were 1$2. The total assets of the bank are 33447.9 billion yuan, an increase of 16 percent over the beginning of the year19% by the end of 2023; The total amount of new credit was 22243.9 billion, an increase of 15 percent year-on-year00%；Total savings amounted to 24793.9 billion, an increase of 16 from the beginning of the year16%；The bad debt ratio is 075%, 006 basis points. This is an increase of 1 from the beginning of the year11 percentage points to 53788%。
Boen Technology: 15.33 million shares of listed companies will be unlocked on March 7.
Boen Holdings issued a notice that the pre-IPO part of the ban will be lifted and can be circulated in the market, and the total number of ** shares released this time is 15.33 million shares, about 954%, representing 3799%；The lifting of the ban** will be listed for trading on Thursday, March 7, 2022.